Upcoming drug delivery talk sees West Pharmaceutical Services stock fall 1.92% amid weak technical signals

West Pharmaceutical Services (WST) stock fell 1.92% amidst weak technical signals, coinciding with the upcoming presentation by Katie Falcone at the SAE Media Group PFS & Injectable Drug Devices East Coast Conference. Technical indicators suggest persistent selling pressure and a low probability of an upside move, with WST consolidating between $240.50 and $245.90. The stock is currently trading below its short and medium-term moving averages, pointing to potential further downside or sideways movement.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin